LiPlasome Pharma
LiPlasome Pharma is a biotechnology company providing a liplasomal reformulation of anticancer drugs.
1
Funding Rounds
$8.0m
Money raised
Overview
LiPlasome Pharma is a biotechnology company providing a liplasomal reformulation of anticancer drugs.
- Website:
Funding series
Funding Series Analysis
The company LiPlasome Pharma has raised a total of $8.01m in funding over 1 rounds.
Key Insights:
- LiPlasome Pharma Series B round: $8.01m
LiPlasome Pharma Series B round
$8.01m